360 filings
Page 15 of 18
8-K
cmm71 c790t6
17 Aug 09
Entry into a Material Definitive Agreement
12:00am
8-K
du6644p
12 Aug 09
Dynavax Announces European Development Strategy for Heplisav Hepatitis B Vaccine
12:00am
8-K
m2sbusx10iwj
7 Aug 09
Departure of Directors or Certain Officers
12:00am
8-K
3xzgw2wh
5 Aug 09
Results of Operations and Financial Condition
12:00am
8-K
70ien
10 Jun 09
Departure of Directors or Certain Officers
12:00am
8-K
88252mxa5h85 6wc
5 Jun 09
Departure of Directors or Certain Officers
12:00am
8-K
px7 trr50t
3 Jun 09
Dynavax Presents Additional Phase 3 Data for Heplisav(tm) Hepatitis B Vaccine at DDW Medical Conference
12:00am
8-K
hbd yyb59oi
30 Apr 09
Dynavax Presents Data from
12:00am
8-K
c32fx8y 74n8
29 Apr 09
Dynavax Announces First Quarter 2009 Financial Results
12:00am
8-K
vin9exbncqt
28 Apr 09
Dynavax Presents Additional Phase 3 Data for Heplisav(tm) Hepatitis B Vaccine at Easl Medical Conference
12:00am
8-K
8w2lr
13 Mar 09
Departure of Directors or Certain Officers
12:00am
8-K
pgk6qe4r4hg05 yuo7
2 Mar 09
Results of Operations and Financial Condition
12:00am
8-K
dz47ev
9 Feb 09
Other Events
12:00am
8-K
la15q
2 Feb 09
Departure of Directors or Certain Officers
12:00am
8-K
brqb85xsbc
19 Dec 08
Termination of a Material Definitive Agreement
12:00am
8-K
l080wu it11ygytso
17 Dec 08
GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance
12:00am
8-K
bpfgyp5vy35fam npt4
8 Dec 08
Dynavax Presents Preclinical Data Supporting its
12:00am
8-K
tlc5hx45
25 Nov 08
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
quh38 4ys
14 Nov 08
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
m8tn5
6 Nov 08
Entry into a Material Definitive Agreement
12:00am